Increased lipid availability for three days reduces whole body glucose uptake, impairs muscle mitochondrial function and initiates opposing effects on PGC-1[alpha] promoter methylation in healthy subjects

FFA and FFA metabolites cause insulin resistance and impair beta cell function. The goal of our research was to examine whether elevation of plasma FFA impairs mitochondrial function and alters PGC-1[alpha] promoter methylation. In this uncontrolled, change from baseline study design, insulin sensit...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:PloS one 2017-12, Vol.12 (12), p.e0188208
Hauptverfasser: Eldor, Roy, Norton, Luke, Fourcaudot, Marcel, Galindo, Cynthia, DeFronzo, Ralph A, Abdul-Ghani, Muhammad
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue 12
container_start_page e0188208
container_title PloS one
container_volume 12
creator Eldor, Roy
Norton, Luke
Fourcaudot, Marcel
Galindo, Cynthia
DeFronzo, Ralph A
Abdul-Ghani, Muhammad
description FFA and FFA metabolites cause insulin resistance and impair beta cell function. The goal of our research was to examine whether elevation of plasma FFA impairs mitochondrial function and alters PGC-1[alpha] promoter methylation. In this uncontrolled, change from baseline study design, insulin sensitivity and glucose-stimulated insulin secretion were measured in 9 normal glucose tolerant subjects before and after 3 day lipid infusion to elevate plasma FFA concentration. Vastus lateralis muscle biopsies were obtained and mitochondrial function, PGC-1[alpha] expression, and PGC-1[alpha] promoter methylation were quantitated. Increased plasma FFA (440±93 [mu]mol/Lto 997±242 [mu]M, p
doi_str_mv 10.1371/journal.pone.0188208
format Article
fullrecord <record><control><sourceid>gale</sourceid><recordid>TN_cdi_gale_infotracmisc_A519675878</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A519675878</galeid><sourcerecordid>A519675878</sourcerecordid><originalsourceid>FETCH-LOGICAL-g1668-91177fb61d63cf02fe8cb328684e7ec991d1c8a4a1939eea667410d8eaba9ea03</originalsourceid><addsrcrecordid>eNqNkU-LFDEQxRtRcF39Bh4KBEGwx073TDp9XAbdHVhY8d9FZKhOKtMZ00mTpNX5jvuhzLoeZsCD1KGKx--9w6uieM6qBWta9mbv5-DQLibvaFExIepKPCjOWNfUJa-r5uHR_bh4EuO-qlaN4PysuN04GQgjKbBmMgrwBxqLvbEmHUD7AGkIRKDwECGQmiVF-Dl4S9B7dYCdnaWPBPOU8Du9BjNOaEKEcY4yM6NJXg7eqWDQgp6dTMY7QKfAOJMMphznp8lH43ZAWpNMWXDw_nJdsq9opwG_wRT86BMFGCkNB4t_MoyDgdBmAeLc7--MT4tHGm2kZ3_3efH53dtP66vy-uZys764LneMc1F2jLWt7jlTvJG6qjUJ2Te14GJJLcmuY4pJgUvMpXVEyHm7ZJUShD12hFVzXry4z92hpa1x2qeAcjRRbi9WrOPtSrQiU4t_UHkUjUbmV2mT9RPDqxNDZhL9SjucY9xuPn74f_bmyyn78oi9Ly16O9_VGI_B3298vAQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Increased lipid availability for three days reduces whole body glucose uptake, impairs muscle mitochondrial function and initiates opposing effects on PGC-1[alpha] promoter methylation in healthy subjects</title><source>DOAJ Directory of Open Access Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Public Library of Science (PLoS)</source><source>PubMed Central</source><source>Free Full-Text Journals in Chemistry</source><creator>Eldor, Roy ; Norton, Luke ; Fourcaudot, Marcel ; Galindo, Cynthia ; DeFronzo, Ralph A ; Abdul-Ghani, Muhammad</creator><creatorcontrib>Eldor, Roy ; Norton, Luke ; Fourcaudot, Marcel ; Galindo, Cynthia ; DeFronzo, Ralph A ; Abdul-Ghani, Muhammad</creatorcontrib><description><![CDATA[FFA and FFA metabolites cause insulin resistance and impair beta cell function. The goal of our research was to examine whether elevation of plasma FFA impairs mitochondrial function and alters PGC-1[alpha] promoter methylation. In this uncontrolled, change from baseline study design, insulin sensitivity and glucose-stimulated insulin secretion were measured in 9 normal glucose tolerant subjects before and after 3 day lipid infusion to elevate plasma FFA concentration. Vastus lateralis muscle biopsies were obtained and mitochondrial function, PGC-1[alpha] expression, and PGC-1[alpha] promoter methylation were quantitated. Increased plasma FFA (440±93 [mu]mol/Lto 997±242 [mu]M, p<0.001) decreased insulin-stimulated total glucose disposal (TGD) by 25% (p = 0.008), impaired suppression of endogenous glucose production (p = 0.01), and reduced mitochondrial ATP synthesis with complex 1 (34%, p<0.05) and complex 2 (30%, p<0.05) substrates. Lipid infusion had no effect on muscle PGC-1[alpha] RNA expression, total methylation or non-CpG methylation, but methylation of the alternative PGC-1[alpha] promoter decreased (1.30±0.30 to 0.84±0.15% methylated residues/patient*strand, p = 0.055). Within PGC-1[alpha] promoter there was demethylation of CpT residues (0.72±0.16 vs. 0.28±0.10 methylated residues/patient*strand) (p = 0.002), which was inversely correlated with PGC-1[alpha] mRNA expression (r = -0.94, p<0.0001) and ATP synthesis with complex 1 (r = -0.80, p<0.01) and complex 2 (r = -0.69, p<0.05) substrates. Lipid infusion increased DNMT-3B (methyltransferase associated with PGC-1[alpha] promoter non-CpG methylation) mRNA expression (0.87 ± 0.09 to 1.62 ± 0.22 arbitrary units, p = 0.005), which correlated inversely with CpT demethylation (r = 0.67, p<0.05). Physiologic plasma FFA elevation in NGT individuals has opposing effects on PGC-1[alpha] non-CpG residue methylation (CpT demethylation and increased DNMT-3B expression), which is correlated with changes in PGC-1[alpha] expression and skeletal muscle mitochondrial function.]]></description><identifier>ISSN: 1932-6203</identifier><identifier>EISSN: 1932-6203</identifier><identifier>DOI: 10.1371/journal.pone.0188208</identifier><language>eng</language><publisher>Public Library of Science</publisher><subject>Analysis ; Health aspects ; High fat diet ; Mitochondrial myopathies ; Physiological aspects ; Risk factors ; Transcriptional coactivators</subject><ispartof>PloS one, 2017-12, Vol.12 (12), p.e0188208</ispartof><rights>COPYRIGHT 2017 Public Library of Science</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,778,782,862,27911,27912</link.rule.ids></links><search><creatorcontrib>Eldor, Roy</creatorcontrib><creatorcontrib>Norton, Luke</creatorcontrib><creatorcontrib>Fourcaudot, Marcel</creatorcontrib><creatorcontrib>Galindo, Cynthia</creatorcontrib><creatorcontrib>DeFronzo, Ralph A</creatorcontrib><creatorcontrib>Abdul-Ghani, Muhammad</creatorcontrib><title>Increased lipid availability for three days reduces whole body glucose uptake, impairs muscle mitochondrial function and initiates opposing effects on PGC-1[alpha] promoter methylation in healthy subjects</title><title>PloS one</title><description><![CDATA[FFA and FFA metabolites cause insulin resistance and impair beta cell function. The goal of our research was to examine whether elevation of plasma FFA impairs mitochondrial function and alters PGC-1[alpha] promoter methylation. In this uncontrolled, change from baseline study design, insulin sensitivity and glucose-stimulated insulin secretion were measured in 9 normal glucose tolerant subjects before and after 3 day lipid infusion to elevate plasma FFA concentration. Vastus lateralis muscle biopsies were obtained and mitochondrial function, PGC-1[alpha] expression, and PGC-1[alpha] promoter methylation were quantitated. Increased plasma FFA (440±93 [mu]mol/Lto 997±242 [mu]M, p<0.001) decreased insulin-stimulated total glucose disposal (TGD) by 25% (p = 0.008), impaired suppression of endogenous glucose production (p = 0.01), and reduced mitochondrial ATP synthesis with complex 1 (34%, p<0.05) and complex 2 (30%, p<0.05) substrates. Lipid infusion had no effect on muscle PGC-1[alpha] RNA expression, total methylation or non-CpG methylation, but methylation of the alternative PGC-1[alpha] promoter decreased (1.30±0.30 to 0.84±0.15% methylated residues/patient*strand, p = 0.055). Within PGC-1[alpha] promoter there was demethylation of CpT residues (0.72±0.16 vs. 0.28±0.10 methylated residues/patient*strand) (p = 0.002), which was inversely correlated with PGC-1[alpha] mRNA expression (r = -0.94, p<0.0001) and ATP synthesis with complex 1 (r = -0.80, p<0.01) and complex 2 (r = -0.69, p<0.05) substrates. Lipid infusion increased DNMT-3B (methyltransferase associated with PGC-1[alpha] promoter non-CpG methylation) mRNA expression (0.87 ± 0.09 to 1.62 ± 0.22 arbitrary units, p = 0.005), which correlated inversely with CpT demethylation (r = 0.67, p<0.05). Physiologic plasma FFA elevation in NGT individuals has opposing effects on PGC-1[alpha] non-CpG residue methylation (CpT demethylation and increased DNMT-3B expression), which is correlated with changes in PGC-1[alpha] expression and skeletal muscle mitochondrial function.]]></description><subject>Analysis</subject><subject>Health aspects</subject><subject>High fat diet</subject><subject>Mitochondrial myopathies</subject><subject>Physiological aspects</subject><subject>Risk factors</subject><subject>Transcriptional coactivators</subject><issn>1932-6203</issn><issn>1932-6203</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><recordid>eNqNkU-LFDEQxRtRcF39Bh4KBEGwx073TDp9XAbdHVhY8d9FZKhOKtMZ00mTpNX5jvuhzLoeZsCD1KGKx--9w6uieM6qBWta9mbv5-DQLibvaFExIepKPCjOWNfUJa-r5uHR_bh4EuO-qlaN4PysuN04GQgjKbBmMgrwBxqLvbEmHUD7AGkIRKDwECGQmiVF-Dl4S9B7dYCdnaWPBPOU8Du9BjNOaEKEcY4yM6NJXg7eqWDQgp6dTMY7QKfAOJMMphznp8lH43ZAWpNMWXDw_nJdsq9opwG_wRT86BMFGCkNB4t_MoyDgdBmAeLc7--MT4tHGm2kZ3_3efH53dtP66vy-uZys764LneMc1F2jLWt7jlTvJG6qjUJ2Te14GJJLcmuY4pJgUvMpXVEyHm7ZJUShD12hFVzXry4z92hpa1x2qeAcjRRbi9WrOPtSrQiU4t_UHkUjUbmV2mT9RPDqxNDZhL9SjucY9xuPn74f_bmyyn78oi9Ly16O9_VGI_B3298vAQ</recordid><startdate>20171220</startdate><enddate>20171220</enddate><creator>Eldor, Roy</creator><creator>Norton, Luke</creator><creator>Fourcaudot, Marcel</creator><creator>Galindo, Cynthia</creator><creator>DeFronzo, Ralph A</creator><creator>Abdul-Ghani, Muhammad</creator><general>Public Library of Science</general><scope>IOV</scope><scope>ISR</scope></search><sort><creationdate>20171220</creationdate><title>Increased lipid availability for three days reduces whole body glucose uptake, impairs muscle mitochondrial function and initiates opposing effects on PGC-1[alpha] promoter methylation in healthy subjects</title><author>Eldor, Roy ; Norton, Luke ; Fourcaudot, Marcel ; Galindo, Cynthia ; DeFronzo, Ralph A ; Abdul-Ghani, Muhammad</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-g1668-91177fb61d63cf02fe8cb328684e7ec991d1c8a4a1939eea667410d8eaba9ea03</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Analysis</topic><topic>Health aspects</topic><topic>High fat diet</topic><topic>Mitochondrial myopathies</topic><topic>Physiological aspects</topic><topic>Risk factors</topic><topic>Transcriptional coactivators</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Eldor, Roy</creatorcontrib><creatorcontrib>Norton, Luke</creatorcontrib><creatorcontrib>Fourcaudot, Marcel</creatorcontrib><creatorcontrib>Galindo, Cynthia</creatorcontrib><creatorcontrib>DeFronzo, Ralph A</creatorcontrib><creatorcontrib>Abdul-Ghani, Muhammad</creatorcontrib><collection>Gale In Context: Opposing Viewpoints</collection><collection>Gale In Context: Science</collection><jtitle>PloS one</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Eldor, Roy</au><au>Norton, Luke</au><au>Fourcaudot, Marcel</au><au>Galindo, Cynthia</au><au>DeFronzo, Ralph A</au><au>Abdul-Ghani, Muhammad</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Increased lipid availability for three days reduces whole body glucose uptake, impairs muscle mitochondrial function and initiates opposing effects on PGC-1[alpha] promoter methylation in healthy subjects</atitle><jtitle>PloS one</jtitle><date>2017-12-20</date><risdate>2017</risdate><volume>12</volume><issue>12</issue><spage>e0188208</spage><pages>e0188208-</pages><issn>1932-6203</issn><eissn>1932-6203</eissn><abstract><![CDATA[FFA and FFA metabolites cause insulin resistance and impair beta cell function. The goal of our research was to examine whether elevation of plasma FFA impairs mitochondrial function and alters PGC-1[alpha] promoter methylation. In this uncontrolled, change from baseline study design, insulin sensitivity and glucose-stimulated insulin secretion were measured in 9 normal glucose tolerant subjects before and after 3 day lipid infusion to elevate plasma FFA concentration. Vastus lateralis muscle biopsies were obtained and mitochondrial function, PGC-1[alpha] expression, and PGC-1[alpha] promoter methylation were quantitated. Increased plasma FFA (440±93 [mu]mol/Lto 997±242 [mu]M, p<0.001) decreased insulin-stimulated total glucose disposal (TGD) by 25% (p = 0.008), impaired suppression of endogenous glucose production (p = 0.01), and reduced mitochondrial ATP synthesis with complex 1 (34%, p<0.05) and complex 2 (30%, p<0.05) substrates. Lipid infusion had no effect on muscle PGC-1[alpha] RNA expression, total methylation or non-CpG methylation, but methylation of the alternative PGC-1[alpha] promoter decreased (1.30±0.30 to 0.84±0.15% methylated residues/patient*strand, p = 0.055). Within PGC-1[alpha] promoter there was demethylation of CpT residues (0.72±0.16 vs. 0.28±0.10 methylated residues/patient*strand) (p = 0.002), which was inversely correlated with PGC-1[alpha] mRNA expression (r = -0.94, p<0.0001) and ATP synthesis with complex 1 (r = -0.80, p<0.01) and complex 2 (r = -0.69, p<0.05) substrates. Lipid infusion increased DNMT-3B (methyltransferase associated with PGC-1[alpha] promoter non-CpG methylation) mRNA expression (0.87 ± 0.09 to 1.62 ± 0.22 arbitrary units, p = 0.005), which correlated inversely with CpT demethylation (r = 0.67, p<0.05). Physiologic plasma FFA elevation in NGT individuals has opposing effects on PGC-1[alpha] non-CpG residue methylation (CpT demethylation and increased DNMT-3B expression), which is correlated with changes in PGC-1[alpha] expression and skeletal muscle mitochondrial function.]]></abstract><pub>Public Library of Science</pub><doi>10.1371/journal.pone.0188208</doi><tpages>e0188208</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1932-6203
ispartof PloS one, 2017-12, Vol.12 (12), p.e0188208
issn 1932-6203
1932-6203
language eng
recordid cdi_gale_infotracmisc_A519675878
source DOAJ Directory of Open Access Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Public Library of Science (PLoS); PubMed Central; Free Full-Text Journals in Chemistry
subjects Analysis
Health aspects
High fat diet
Mitochondrial myopathies
Physiological aspects
Risk factors
Transcriptional coactivators
title Increased lipid availability for three days reduces whole body glucose uptake, impairs muscle mitochondrial function and initiates opposing effects on PGC-1[alpha] promoter methylation in healthy subjects
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-15T13%3A16%3A16IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Increased%20lipid%20availability%20for%20three%20days%20reduces%20whole%20body%20glucose%20uptake,%20impairs%20muscle%20mitochondrial%20function%20and%20initiates%20opposing%20effects%20on%20PGC-1%5Balpha%5D%20promoter%20methylation%20in%20healthy%20subjects&rft.jtitle=PloS%20one&rft.au=Eldor,%20Roy&rft.date=2017-12-20&rft.volume=12&rft.issue=12&rft.spage=e0188208&rft.pages=e0188208-&rft.issn=1932-6203&rft.eissn=1932-6203&rft_id=info:doi/10.1371/journal.pone.0188208&rft_dat=%3Cgale%3EA519675878%3C/gale%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rft_galeid=A519675878&rfr_iscdi=true